CLDI.WS

Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00
CLDI.WS

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

CLDI.WS was delisted on the 17th of October, 2024.

Back to rankings

22 hedge funds and large institutions have $5.93M invested in Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 in 2021 Q4 according to their latest regulatory filings, with 22 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
22
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$4.82M
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.96M
2
+$495K
3
+$495K
4
AA
AQR Arbitrage
Connecticut
+$490K
5
PAMP
Polar Asset Management Partners
Ontario, Canada
+$371K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.96M
2
$495K
3
$495K
4
$490K
5
$371K
6
$328K
7
$315K
8
$254K
9
$245K
10
$222K
11
$179K
12
$162K
13
$144K
14
$57K
15
$51K
16
$50K
17
$45K
18
$16K
19
$13K
20
$13K
21
$11K
22
$10K
23
$1K